LigBuilder 2: A practical de novo drug design approach

Journal of Chemical Information and Modeling

Volumn 51, Issue 5, 2011, Pages 1083-1091

  Yuan, Yaxia ^a,b   Pei, Jianfeng ^b   Lai, Luhua ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; BIOSYNTHESIS;

BEST FIT; CAVITY DETECTION; DRUG DESIGN; DRUGABILITY; PROTEIN STRUCTURES; SET OF RULES;

LIGANDS;

LIGAND; PROTEIN; PROTEIN BINDING;

AGONISTS; ALGORITHM; ANTAGONISTS AND INHIBITORS; BINDING SITE; CHEMICAL PHENOMENA; CHEMISTRY; COMPUTER PROGRAM; DRUG DESIGN; HYDROGEN BOND; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; PROTEIN BINDING;

ALGORITHMS; BINDING SITES; DRUG DESIGN; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIGANDS; PROTEIN BINDING; PROTEINS; SOFTWARE;

EID: 79960250991     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci100350u     Document Type: Article

References (36)

1. Nishibata, Y.; Itai, A. Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation. Tetrahedron 1991, 47, 8885-8990.
2. Bohm, H. J. The computer program LUDI: A new method for the de novo design of enzyme inhibitors. J. Comput.-Aided Mol. Des. 1992, 6 61-78.
3. Gillet, V.; Johnson, A. P.; Mata, P.; Sike, S.; Williams, P. SPROUT: A program for structure generation. J. Comput.-Aided Mol. Des. 1993, 7, 127-153.
4. Eisen, M. B.; Wiley, D. C.; Karplus, M.; Hubbard, R. E. HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 1994, 19 199-221. (Pubitemid 24215048)
5. Bohacek, R. S.; McMartin, C. Multiple highly diverse structures complementary to enzyme binding sites: Results of extensive application of de novo design method incorporating combinatorial growth. J. Am. Chem. Soc. 1994, 116 5560-5571.
6. Clark, D. E.; Frenkel, D.; Levy, S. A.; Li, J.; Murray, C. W.; Robson, B.; Waszkowycz, B.; Westhead, D. R. Pro-Ligand - an Approach to De-Novo Molecular Design 1. Application to the Design of Organic-Molecules. J. Comput-Aided. Mol. Des. 1995, 9, 13-32.
7. Pearlman, D. A.; Murcko, M. A. CONCERTS: Dynamic connection of fragments as an approach to de novo ligand design. J. Med. Chem. 1996, 39 1651-1663. (Pubitemid 26120068)
8. Luo, Z. W.; Wang, R. X.; Lai, L. H. RASSE: A New Method for Structure-Based Drug Design. J. Chem. Inf. Comput. Sci. 1996, 36, 1187-1194.
9. LeapFrog; Tripos, Inc.: St Louis, MO, USA.
10. LEA3D: A Computer-Aided Ligand Design for Structure-Based Drug Design. J. Med. Chem. 2005, 48, 2457-2468
11. Wang, R.; Gao, Y.; Lai, L. A Multi-Purpose Program for Structure-Based Drug Design. J. Mol. Model. 2000, 6 498-516.
12. Schneider, G.; Fechner, U. Computer-based de novo design of drug-like molecules. Nat. Rev. Drug Discovery 2005, 4, 649-663. (Pubitemid 41149759)
13. Schneider, G.; Hartenfeller, M.; Reutlinger, M.; Tanrikulu, Y.; Proschak, E.; Schneider, P. Voyages to the (un)known: adaptive design of bioactive compounds. Trends Biotechnol. 2009, 27 (1), 18-26.
14. Mauser, H.; Guba, W. Recent developments in de novo design and scaffold hopping. Curr. Opin. Drug Discovery Dev. 2008, 11 365-374. (Pubitemid 351572446)
15. Schneider, G.; Lee, M. L.; Stahl, M.; Schneider, P. De novo design of molecular architectures by evolutionary assembly of drug derived building blocks. J. Comput.-Aided Mol. Des. 2000, 14 487-494. (Pubitemid 30386823)
16. Kandil, S.; Biondaro, S.; Vlachakis, D.; Cummins, A C.; Coluccia, A.; Berry, C.; Leyssen, P.; Neyts, J.; Brancale, A. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach. Bioorg. Med. Chem. Lett. 2009, 19 (11), 2935-2937.
17. Babine, R. E.; Bleckman, T. M.; Kissinger, C. R.; Showalter, R.; Pelletier, L. A.; Lewis, C.; Tucker, K.; Moomaw, E.; Parge, H. E.; Villafranca, J. E. Design, Synthesis and X-Ray Crystallographic Studies of Novel Fkbp-12 Ligands. Bioorg. Med. Chem. Lett. 1995, 3, 1719-1724.
18. Goldberg, D. R.; Hao, M. H.; Qian, K. C.; Swinamer, A. D.; Gao, D. H. A.; Xiong, Z.; Sarko, C.; Berry, A.; Lord, J.; Magolda, R. L.; Fadra, T.; Kroe, R. R.; Kukulka, A.; Madwed, J. B.; Martin, L.; Pargellis, C.; Skow, D.; Song, J. J.; Tan, Z. L.; Torcellini, C. A.; Zimmitti, C. S.; Yee, N. K.; Moss, N. Discovery and optimization of p38 Inhibitors via computer-assisted drug design. J. Med. Chem. 2007, 50, 4016-4026. (Pubitemid 47301734)
19. Wang, R. X.; Liu, L.; Lai, L. H.; Tang, Y. Q. SCORE: A new empirical method for estimating the binding affinity of a protein-ligand complex. J. Mol. Model. 1998, 4, 379-394. (Pubitemid 128664733)
20. Yates, A. S.; Doughty, S. W.; Kendall, D. A.; Kellam, B. Chemical modification of the naphthoyl 3-position of JWH-015: In search of a fluorescent probe to the cannabinoid CB2 receptor. Bioorg. Med. Chem. Lett. 2005, 15, 3758-3762. (Pubitemid 41038973)
21. Tondel, K.; Drablos, F. Design of selective inhibitors of tyrosine kinase 2. Lett. Drug Des. Discovery 2005, 2, 507-515. (Pubitemid 41727445)
22. Huang, B. D.; Schroeder, M. LIGSITE(csc): predicting ligand binding sites using the Connolly surface and degree of conservation. BMC Struct. Biol. 2006, 6 ARTN 19.
23. Laurie, A. T. R.; Jackson, R. M. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 2005, 21 (9), 1908-1916. (Pubitemid 40668026)
24. Laskowski, R. A Surfnet - a Program for Visualizing Molecular-Surfaces, Cavities, and Intermolecular Interactions. J. Mol. Graphics 1995, 13 (5), 323.
25. Chen, H.; Van Duyne, R.; Zhang, N.; Kashanchi, F.; Zeng, C. A novel binding pocket of cyclin-dependent kinase 2. Proteins 2009, 74, 122-132.
26. Chen, J.; Lai, L. H. pocket v.2: Further developments on receptor-based pharmacophore modeling. J. Chem. Inf. Model. 2006, 46, 2684-2691. (Pubitemid 46008137)
27. Derwent Information Ltd., Derwent House, 14 Great Queen Street, London, WC2B 5DF, UK. Web address: http://www.derwent.co.uk/ (accessed Feb. 2002).
28. Pei, J. F.; Wang, Q.; Zhou, J. J.; Lai, L. H. Estimating protein-ligand binding free energy: Atomic solvation parameters for partition coefficient and solvation free energy calculation. Proteins 2004, 57, 651-664. (Pubitemid 39626987)
29. Wang, R. X.; Fang, X. L.; Lu, Y. P.; Yang, C. Y.; Wang, S. M. The PDBbind database: Methodologies and updates. J. Med. Chem. 2005, 48 4111-4119.
30. Ghose, A. K.; Viswanadhan, V. N.; John, J.; Wendoloski, J. J. A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases. J. Comb. Chem. 1999, 1 (1), 55-68.
31. Law, J.; Zsoldos, Z.; Simon, A.; Reid, D.; Liu, Y.; Khew, S. Y.; Johnson, A. P.; Major, S.; Wade, R. A.; Ando, H. Y. Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule Generation. J. Chem. Inf. Model. 2009, 49, 593-602.
32. Fischer, E.; Speier, A. Darstellung der Ester. Chem. Ber. 1895, 28, 3252-3258.
33. Paterson, I. α-Alkylation of ketones, esters, and lactones: zinc bromide-catalysed alkylation of o-silylated enolates, a synthesis of (±)-ar-turmerone. Tetrahedron Lett. 1979, 20, 1519-1520.
34. Irwin, J. J.; Shoichet, B. K. ZINC - A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 2005, 45, 177-182. (Pubitemid 40736970)
35. Boda, K.; Seidel, T.; Gasteiger, J. Structure and reaction based evaluation of synthetic accessibility. J. Comput.-Aided Mol. Des. 2007, 21 311-325. Online web service: http://www.molecular-networks.com/online-demos/ sylvia/ (accessed Jan. 16, 2011). (Pubitemid 47054812)
36. Ni, S. S.; Yuan, Y. X.; Huang, J.; Mao, X. N.; Lv, M. S.; Zhu, J.; Shen, X.; Pei, J. F.; Lai, L. H.; Jiang, H. L.; Li, J. Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de novo Drug Design Approach. J. Med. Chem. 2009, 52, 5295-5298.